Evidence map›Paper›PMID 28891335›Full record

ReviewDrug delivery2017

Development of DNA tetrahedron-based drug delivery system.

Yue Hu, Zhou Chen, He Zhang, Mingkai Li, Zheng Hou, Xiaoxing Luo, Xiaoyan Xue

Abstract readReview
In one paragraph

Review in Drug delivery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Mini Review On: The Roles of DNA Nanomaterials in Phototherapy.International journal of nanomedicine · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yue Hua Department of Pharmacology , Fourth Military Medical University , Xi'an , China.
Zhou Chena Department of Pharmacology , Fourth Military Medical University , Xi'an , China.
He Zhangb Student Brigade , Fourth Military Medical University , Xi'an , China.
Mingkai Lia Department of Pharmacology , Fourth Military Medical University , Xi'an , China.
Zheng Houa Department of Pharmacology , Fourth Military Medical University , Xi'an , China.
Xiaoxing Luoa Department of Pharmacology , Fourth Military Medical University , Xi'an , China.
Xiaoyan Xuea Department of Pharmacology , Fourth Military Medical University , Xi'an , China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanocarriers of drugs have attracted significant attention to tackle the problems of drug resistance or nucleic acid drug delivery, which can optimize pharmaceutical parameters and enhance the cellular uptake efficiency. Nowadays, DNA nanostructure presents an opportunity in the field of nanomaterial due to its precise control in shape and size, excellent biocompatibility, as well as multiple sites for targeting decoration. DNA tetrahedron, which is stable and easily synthesized, is used for various applications, including nuclear magnetic resonance imaging, molecular diagnosis, targeting drug delivery, and so on. In this review, we will discuss the applications of DNA tetrahedron about drug delivery, intracellular routes and its fates. Also challenges and possible solutions for developing DNA tetrahedron-based drug delivery system are detailed.

Indexed as

Drug Delivery SystemsDNAHumansMagnetic Resonance ImagingNanostructuresPharmaceutical PreparationsDNAPharmaceutical PreparationsDNA tetrahedrondrug delivery systemmodificationsNanotechnologyprogrammable structures

Identifiers

PMID28891335
PMCPMC8241089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.